A Phase II, Open Label Study of AT-101 in Combination with Rituximab in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia. Evaluation of Two Dose Regimens.
Year: 2007
Type: article
Study design: Clinical Trial
Source: Blood
Authors: Januario E. Castro, Olivier J. Loria, Robier A. Aguillon, Danelle James, Cesar A. Llanos, Laura Rassenti, Brian A. Wood, Jon T. Homlund, Thomas J. Kipps
Institutions: University of California San Diego, Moores Cancer Center
Language: English
Subfield: Genetics (clinical)
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2559124879